Related Experiment Video
Updated: Apr 14, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
[Neuroendocrine tumors of the kidneys]
1Institut für Klinische Pathologie, UniversitätsSpital Zürich, Schmelzbergstrasse 12, 8091, Zürich, Schweiz, holger.moch@usz.ch.
Abstract:
The 2004 World Health Organization (WHO) classification of renal cancer includes renal carcinoid and neuroendocrine cancer of the kidneys in the group of primary renal neuroendocrine tumors. The histological features of primary renal carcinoids are similar to those of neuroendocrine tumors found in other anatomical locations. Primary carcinoid tumors of the kidneys are frequently misdiagnosed as other kidney cancers, such as papillary renal cell carcinoma, mesonephric tumors, Wilms tumor (WT) and undifferentiated carcinoma. Immunohistochemical staining results are consistent with the diagnosis of a neuroendocrine tumor with immunoreactivity for synaptophysin, chromogranin, CD56, and neuron-specific enolase (NSE). Positive expression of CD99 can also be seen. There is mainly absence of WT1, cytokeratin 7, cytokeratin 20, thyroid transcription factor (TTF1) and LCA, ruling out most other differential diagnoses. Renal carcinoid tumors are regarded as low-grade neuroendocrine tumors; however, many studies have demonstrated metastatic disease in patients with renal carcinoid tumors. The prognostic value of histological parameters is uncertain. Some studies have correlated poor patient prognosis with increased mitotic activity, presence of necrosis and cytological atypia. Cases with higher mitotic rates of > 2 mitoses/10 high power fields (HPF) developed metastases more frequently; therefore, the WHO classification of neuroendocrine tumors used in other organs is recommended for primary renal carcinoid tumors.
Insights
Primary renal neuroendocrine tumors, or carcinoids, share histological traits with those in other sites but are often misdiagnosed. Immunohistochemistry aids diagnosis, and WHO grading is recommended due to metastatic potential.
Area of Science:
- Oncology
- Pathology
- Urology
Context:
- The 2004 World Health Organization (WHO) classification categorizes renal carcinoid and neuroendocrine kidney cancers as primary renal neuroendocrine tumors.
- Primary renal carcinoids exhibit histological similarities to neuroendocrine tumors in other anatomical locations.
- These tumors are frequently misdiagnosed as other kidney cancers, including papillary renal cell carcinoma, mesonephric tumors, Wilms tumor (WT), and undifferentiated carcinoma.
Purpose:
- To differentiate primary renal neuroendocrine tumors from other renal malignancies.
- To highlight the diagnostic utility of immunohistochemical markers.
- To recommend the application of the WHO classification system for neuroendocrine tumors to renal carcinoids.
Summary:
- Immunohistochemical staining reveals characteristic neuroendocrine markers such as synaptophysin, chromogranin, CD56, and neuron-specific enolase (NSE), with potential CD99 positivity.
- Absence of WT1, cytokeratin 7, cytokeratin 20, thyroid transcription factor (TTF1), and LCA helps rule out differential diagnoses.
- Despite being considered low-grade, renal carcinoid tumors can metastasize, with increased mitotic activity, necrosis, and cytological atypia correlating with poorer prognosis.
Impact:
- Accurate diagnosis of primary renal neuroendocrine tumors through characteristic histology and immunohistochemistry.
- Improved differential diagnosis, reducing misclassification as other common kidney cancers.
- Application of established WHO grading for neuroendocrine tumors to renal carcinoids may improve prognostic assessment and patient management.
More Related Videos
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
Related Concept Videos
Anatomy of the Adrenal Glands
These glands possess a distinctive yellow tinge due to the stored cholesterol and fatty acids required for hormone synthesis. They are encased in a fibrous capsule and cushioned by fat.
The adrenal gland comprises two distinct...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Structures of the Endocrine System
The Endocrine System